Nomura Holdings Inc Charles River Laboratories International, Inc. Transaction History

Nomura Holdings Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $776,645 - $1.01 Million	-3,763 Reduced 36.67%	6,500 $1.34 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $2.09 Million - $2.81 Million	10,263 New	10,263 $2.78 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $167,810 - $243,616	1,020 New	1,020 $241,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $196,373 - $290,908	-962 Closed	0 $0
Q1 2022 May 18, 2022	BUY	$255.51 - $362.11 $30,661 - $43,453	120 Added 14.25%	962 $278,000
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $209,773 - $267,861	-597 Reduced 41.49%	842 $317,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $98,749 - $121,449	265 Added 22.57%	1,439 $600,000
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $1.64 Million - $2.07 Million	-5,576 Reduced 82.61%	1,174 $434,000
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $1.69 Million - $2.02 Million	6,750 New	6,750 $1.96 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $237,680 - $379,440	-2,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $197,800 - $356,680	2,000 New	2,000 $253,000

696

51.8M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.33B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.